• No results found

Cover Page The handle http://hdl.handle.net/1887/54940

N/A
N/A
Protected

Academic year: 2021

Share "Cover Page The handle http://hdl.handle.net/1887/54940"

Copied!
6
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

Cover Page

The handle http://hdl.handle.net/1887/54940 holds various files of this Leiden University dissertation.

Author: Burgmans, M.C.

Title: Advancements in minimally invasive image-guided liver therapies

Issue Date: 2017-10-26

(2)

Advancements in minimally invasive image-guided liver therapies

Mark Burgmans

(3)

ISBN: 978-94-92683-84-7

Layout and printed by: Optima Grafische Communicatie, Rotterdam, the Netherlands

(www.ogc.nl)

(4)

Advancements in minimally invasive image-guided liver therapies

Proefschrift

ter verkrijging van

de graad van Doctor aan de Universiteit Leiden, op gezag van Rector Magnificus prof.mr. C.J.J.M. Stolker,

volgens besluit van het College voor Promoties te verdedigen op 26 oktober 2017

klokke 16.15 uur

door

Mark Christiaan Burgmans geboren te Leiden

in 1972

(5)

Promotor:

Prof. dr. A. de Roos

Co-promotor:

Dr. A.R. van Erkel

Leden promotie commissie:

Prof. dr. W.P.Th.M. Mali, Universitair Medisch Centrum Utrecht

Prof. dr. O.M. van Delden, Academisch Medisch Centrum

Prof. dr. L.F. de Geus-Oei, Leids Universitair Medisch Centrum

Dr. A.L. Vahrmeijer, Leids Universitair Medisch Centrum

Dr. M.J. Coenraad, Leids Universitair Medisch Centrum

(6)

Contents

Chapter 1 General introduction 7

PARt I PeRCUtAneoUs RADIoFReQUenCY ABLAtIon

Chapter 2 Differences in patient characteristics and midterm outcome between Asian and European patients treated with radiofrequency ablation for hepatocellular carcinoma

19

Chapter 3 Phantom study investigating the accuracy of manual and automatic image fusion with the General Electric Logiq E9: implications for use in percutaneous liver interventions

35

Chapter 4 Local tumor progression and survival rates after combined radiofrequency ablation and drug-eluting bead chemoembolization in unresectable hepatocellular carcinoma

53

PARt II tRAnsARteRIAL LIVeR tHeRAPIes

Chapter 5 Pilot study evaluating catheter-directed contrast-enhanced ultrasound compared to catheter-directed computed tomography hepatic arteriography as adjuncts to digital subtraction angiography to guide transarterial chemoembolization

71

Chapter 6 Radioembolization with infusion of Y90 microspheres into a right inferior phrenic artery with hepatic tumor supply is feasible and safe

83

Chapter 7 Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning Y90 radioembolization

99

Chapter 8 Image-guided personalized predictive dosimetry by artery-specific SPECT/CT partition modeling for safe and effective Y90 radioembolization

113

Chapter 9 Percutaneous isolated hepatic perfusion for the treatment of unresectable liver malignancies

137

Chapter 10 Prospective clinical and pharmacological evaluation of the Delcath System’s second generation (GEN2) hemofiltration system in patients undergoing percutaneous hepatic perfusion with melphalan

161

PARt III PAtIent MAnAGeMent

Chapter 11 Impact on patient safety and satisfaction of implementation of an outpatient clinic in interventional radiology (IPSIPOLI-study): a quasi-experimental prospective study

181

Chapter 12 General discussion and future perspectives 199

Appendix Nederlandse samenvatting 211

Curriculum vitae 219

List of publications 221

Dankwoord 225

Referenties

GERELATEERDE DOCUMENTEN

The differences in cumulative incidence of recurrence and death between the Asian and European group are likely related to a multitude of variables, such as patient selection,

If the translation point was placed in the left hepatic vein, registration accuracy improved for the liver lesion but not for the center of the right kidney.. If the translation

Despite the additional treatment with DEBTACE however, patients in the combined treatment group had significantly lower mean local tumor progression free-survival rates compared

Complete tumor enhancement upon contrast injection from a super-selective hepatic artery position allows the operator to feel confident that the entire tumor is targeted,

We hypothesized that selective radioembolization into the IPAs is feasible and safe in selected patients when using a combination of digital subtraction angiography (DSA),

Of these 14 patients, 4 patients underwent planar Y90 bremsstralung scintigraphy and the other 10 patients had additional Y90 bremsstrahlung SPECT/CT of the abdomen. None of the

N/AN/ANo14.5% 16Gy2.3GBqIndeterminate; ill-defined tumor margins; subcentimeter lesions † ¶ RE: Y90 radioembolization; T/N ratio: tumor-to-normal liver ratio; N/A: not applicable;

A phase I–II study of isolated hepatic perfusion using melphalan with or without tumor necrosis factor for patients with ocular melanoma metastatic to liver.. Clin